News Letters 2016

Would you like to submit an article for inclusion in IMPACT? Click here for guidance notes.

Issue Number



Volume 10 
Link opens in new window004 PDF 118KB

November 2016

  • Cardiovascular Risk With (NSAIDs) and COX-2 Inhibitors
  • Managing drug-drug interactions with Direct Acting Antivirals (DAAs) used to treat Hepatitis C
  • Scottish Therapeutics Utility

Volume 10
Link opens in new window03 PDF 118KB

July 2016

  • Polypharmacy Guidance for the safe and effective use of multiple medicines to manage long term conditions
  • Limited awareness of the direct oral anticoagulants; a patient safety issue

Volume 10
Link opens in new window02 PDF 78KB

May 2016

  • Primary Care Trimethoprim Prescribing - Snapshot Audit
  • Apremilast for Psoriasis and Psoriatic Arthritis
  • Strong opioids and co-prescribing of laxatives 

Volume 10
Link opens in new window01 PDF 88KB

April 2016

  • Valproate and risk of abnormal pregnancy outcomes: new communication materials
  • EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes  
  • OctasaŽ now preferred brand of MR mesalazine in Grampian  
  • 'Don't Waste A Breath' Campaign - Poster and Facebook re-fresh